Literature DB >> 20682394

MUC1 oncogene amplification correlates with protein overexpression in invasive breast carcinoma cells.

E Lacunza1, M Baudis, A G Colussi, A Segal-Eiras, M V Croce, M C Abba.   

Abstract

The MUC1 gene is aberrantly overexpressed in approximately 90% of human breast cancers. Several studies have shown that MUC1 overexpression is due to transcriptional regulatory events. However, the importance of gene amplification as a mechanism leading to the increase of MUC1 expression in breast cancer has been poorly characterized. The aim of this study was to evaluate the role of MUC1 gene amplification and protein expression in human breast cancer development. By means of real-time quantitative polymerase chain reaction and immunohistochemical methods, 83 breast tissue samples were analyzed for MUC1 gene amplification and protein expression. This analysis showed MUC1 genomic amplification and a positive association with the histopathological group in 12% (1 out of 8) of benign lesions and 38% (23 out of 60) of primary invasive breast carcinoma samples (P = 0.004). Array-comparative genomic hybridization meta-analysis of 886 primary invasive breast carcinomas obtained from 22 studies showed MUC1 genomic gain in 43.7% (387 out of 886) of the samples. Moreover, we identified a highly statistical significant association between MUC1 gene amplification and MUC1 protein expression assessed by immunohistochemistry and Western blot test (P < 0.0001). In conclusion, this study demonstrated that MUC1 copy number increases from normal breast tissue to primary invasive breast carcinomas in correlation with MUC1 protein expression. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682394     DOI: 10.1016/j.cancergencyto.2010.05.015

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  19 in total

Review 1.  Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

Authors:  Partha Mukhopadhyay; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Maneesh Jain; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-01-26

Review 2.  Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities.

Authors:  Zhiliang Cheng; Ajlan Al Zaki; James Z Hui; Vladimir R Muzykantov; Andrew Tsourkas
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

Review 3.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

Review 4.  MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.

Authors:  D W Kufe
Journal:  Oncogene       Date:  2012-05-14       Impact factor: 9.867

5.  Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?

Authors:  Abdelfattah M Attallah; Mohamed El-Far; Mohamed M Omran; Sanaa O Abdallah; Mohamed A El-Desouky; Ibrahim El-Dosoky; Mohamed A Abdelrazek; Ahmed A Attallah; Mohamed A Elweresh; Gamal E Abdel Hameed; Hadil A Shawki; Karim S Salama; Ahmed M El-Waseef
Journal:  Tumour Biol       Date:  2014-07-30

6.  MUC1 drives c-Met-dependent migration and scattering.

Authors:  Teresa M Horm; Benjamin G Bitler; Derrick M Broka; Jeanne M Louderbough; Joyce A Schroeder
Journal:  Mol Cancer Res       Date:  2012-11-27       Impact factor: 5.852

7.  Molecular mimics of the tumour antigen MUC1.

Authors:  Tharappel C James; Ursula Bond
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

8.  CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.

Authors:  Elisabetta Manuali; Antonio De Giuseppe; Francesco Feliziani; Katia Forti; Cristina Casciari; Maria Chiara Marchesi; Eugenio Pacifico; Karol M Pawłowski; Kinga Majchrzak; Magdalena Król
Journal:  BMC Vet Res       Date:  2012-06-22       Impact factor: 2.741

9.  Immunophenotyping invasive breast cancer: paving the road for molecular imaging.

Authors:  Jeroen F Vermeulen; Aram S A van Brussel; Petra van der Groep; Folkert H M Morsink; Peter Bult; Elsken van der Wall; Paul J van Diest
Journal:  BMC Cancer       Date:  2012-06-13       Impact factor: 4.430

10.  Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses.

Authors:  Katrin Campbell; Vivienne L Young; Braeden C Donaldson; Matthew J Woodall; Nicholas J Shields; Greg F Walker; Vernon K Ward; Sarah L Young
Journal:  Vaccines (Basel)       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.